Search

Search Results

5 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PaperVolume 12, Issue 2pp 1304-1321

  AURKB promotes gastric cancer progression via activation of CCND1 expression

  Relevance score: 0.00

  Min Nie, Yadong Wang, Zenong Yu, Xinyu Li, Yexuan Deng, Ying Wang, Dongjun Yang, Qixiang Li, Xiangwei Zeng, Junyi Ju, Ming Liu, Quan Zhao

  Keywords: AURKB, CCND1, H3S10ph, proliferation, gastric cancer

  Published in Aging on January 25, 2020

  Show abstract
• Research PaperVolume 11, Issue 24pp 12057-12079

  Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients

  Relevance score: 0.00

  Jian-Feng Yang, Shen-Nan Shi, Wen-Hao Xu, Yun-Hua Qiu, Jin-Zhou Zheng, Kui Yu, Xiao-Yun Song, Feng Li, Yu Wang, Rui Wang, Yuan-Yuan Qu, Hai-Liang Zhang, Xi-Qiu Zhou

  Keywords: clear cell renal cell carcinoma, ccRCC, CCND1, PECAM1/CD31, biomarker

  Published in Aging on December 18, 2019

  Show abstract
• Research PaperVolume 16, Issue 8pp 6745-6756

  Exploring the anti-atherosclerosis mechanism of ginsenoside Rb1 by integrating network pharmacology and experimental verification

  Relevance score: 0.00

  Lianjie Hou, Zhiming Zou, Yu Wang, Hui Pi, Zeyue Yuan, Qin He, Yongfang Kuang, Guojun Zhao

  Keywords: ginsenoside Rb1, atherosclerosis, network pharmacology, CCND1

  Published in Aging on March 27, 2024

  Show abstract
• Research PaperVolume 12, Issue 14pp 14775-14790

  The circular RNA circEIF3M promotes breast cancer progression by promoting cyclin D1 expression

  Relevance score: 0.00

  Xiujuan Li, Zhaojun Ren, Yufeng Yao, Jun Bao, Qiao Yu

  Keywords: circEIF3M, miR-33a, triple-negative breast cancer, CCND1

  Published in Aging on July 11, 2020

  Show abstract
• Research PaperVolume 16, Issue 14pp 11208-11223

  Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway

  Relevance score: 0.00

  Yanbin Zhang, Tao Zhang, Long Chen, Zijun Guo, Xiaobing Jiang

  Keywords: osteosarcoma, CCNL1, chemoresistance, PI3K/AKT-mTOR, Adriamycin, prognosis

  Published in Aging on June 26, 2024

  Show abstract